Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Repulsive Guidance Molecule A ELISA Kit (AC3150)
Cat.#: ASET-1739
Specifications
Description Human Repulsive Guidance Molecule A ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Repulsive Guidance Molecule A concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.024 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1884 Human LMX1b ELISA Kit (AC3295) Quantitative inquiry ASET-1492 Human GABARAPL1 ELISA Kit (AC2903) Quantitative inquiry ASET-2205 Human alpha Synuclein ELISA Kit (AC3616) Quantitative inquiry ASET-1379 Human CD11b ELISA Kit (AC2790) Quantitative inquiry ASET-1364 Rat Dio3 ELISA Kit (AC2775) Quantitative inquiry ASET-1503 Mouse NMDAR2A ELISA Kit (AC2914) Quantitative inquiry ASET-1627 Mouse AGRP ELISA Kit (AC3038) Quantitative inquiry ASET-1024 Chicken FGF2 ELISA Kit (AC2435) Quantitative inquiry ASET-2164 Rat GDF6 ELISA Kit (AC3575) Quantitative inquiry ASET-2429 Human PPAR gamma ELISA Kit (AC3840) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket